Holen Sie sich die Stockscreener-App
2.78
0.71%
-0.02
Schlusskurs vom Vortag:
$2.80
Offen:
$2.79
24-Stunden-Volumen:
51,047
Relative Volume:
0.11
Marktkapitalisierung:
$6.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.77M
KGV:
-0.2807
EPS:
-9.9046
Netto-Cashflow:
$-6.52M
1W Leistung:
-4.14%
1M Leistung:
+28.70%
6M Leistung:
-54.05%
1J Leistung:
-72.88%
1-Tages-Spanne:
$2.70
$2.89
1-Wochen-Bereich:
$2.5701
$2.98
52-Wochen-Spanne:
$1.31
$18.90
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Firmenname
Adial Pharmaceuticals Inc
Sektor
Branche
Telefon
434-422-9800
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
2.78 | 6.08M | 0 | -7.77M | -6.52M | -9.9046 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2018-10-30 | Eingeleitet | Maxim Group | Buy |
| 2018-10-11 | Eingeleitet | Dawson James | Buy |
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Price to earnings forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Group takes 14.22% position in Adial Pharmaceuticals (ADIL) - Stock Titan
Enterprise value to EBIT forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals By Investing.com - Investing.com Nigeria
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals - Investing.com
Form 4 Adial Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada
Adial Pharmaceuticals (ADIL) holder Coastlands Capital adds 25,000 shares - Stock Titan
Price to book forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Enterprise value to revenue forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Gains 1.17% as Shares Approach Key Resistance LevelMFI Oversold - dars.gov.et
Coastlands Capital details ADIAL Pharmaceuticals (ADIL) stock and warrant stake - Stock Titan
Insider Conviction: Why Coastlands Capital is Buying Adial Pharmaceuticals Ahead of a Pivotal Phase 3 - Kavout | AI
ADIL stock eyes best day in over 5 years — major pipeline overhaul and $64M raise fuel rally - MSN
Adial Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ADIL) - TradingView
ADIL Forecast — Price Target — Prediction for 2027 - TradingView
Coastlands files 9.98% holding in Adial Pharmaceuticals (ADIL) - Stock Titan
ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally - Stocktwits
Adial Pharmaceuticals Inc (ADIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Net current asset value per share of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals Inc (ADIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Adial Pharmaceuticals Inc (ADIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adial Pharmaceuticals Inc (ADIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Adial Pharmaceuticals Inc (ADIL) Institutional Confidence - TradingKey
Adial Pharmaceuticals Inc (ADIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adial Pharmaceuticals Inc (ADIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Adial Pharmaceuticals Inc (ADIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adial Pharmaceuticals Inc (ADIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Adial closes $32 million financing, grants stock to new executives By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing - The Manila Times
Adial Pharmaceuticals (ADIL) CDO adds RSUs, options and preferred shares after Azora merger - Stock Titan
ADIAL (ADIL) director and CDO Matt Davidson listed in Form 3 filing - Stock Titan
Adial Pharmaceuticals (NASDAQ: ADIL) director buys 36,378 pre-funded warrants - Stock Titan
ADIAL (ADIL) director Wendy Young files initial insider Form 3 statement - Stock Titan
Adial closes $32 million financing, grants stock to new executives - Investing.com
ADIL Initiates Coverage by LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus
ADIL Initiates Coverage by LUCID CAPITAL MARKETS -- Rating Set to Buy - GuruFocus
Lucid Capital Markets initiates Adial Pharmaceuticals stock with buy rating on colitis drug potential - Investing.com UK
Adial Pharmaceuticals (ADIL) Holds Steady at $2.98 as Consolidation NarrowsIchimoku Kumo Twist - newsline.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Adial broadens pipeline with Azora acquisition and up to $64 million financing - The Pharma Letter
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Top Midday Gainers - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics and Sec - GuruFocus
Adial Pharmaceuticals acquires Azora Therapeutics, secures up to $64M financing - MSN
Top movers analysis one hour before the close of the markets on 2026-06-11: top gainers and losers in today's session. - ChartMill
Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics to Enha - GuruFocus
Adial Pharmaceuticals Announces Acquisition Of Azora Therapeutics And Up To $64 Million Financing - TradingView
Adial Pharmaceuticals, Inc. (ADIL) Stock: Strategic Acquisition Positions Company for Clinical Growth - parameter.io
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):